EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vasculoprotective Effects of Sodium-Glucose Co-Transporter Inhibitors in Non-Diabetic Experimental Settings: A Narrative Review

Darius G Buriman iD, Lavinia Noveanu, Adina V Furdui-Lința, Horea B Feier iD, Antigone Lazou iD, Attila Kiss iD, Bruno K Podesser iD, Maria D Dănilă iD, Adrian Sturza, Danina M Muntean

International Journal of Molecular Sciences · 11.03.2026 · 27 (6) · 2573

DOI: 10.3390/ijms27062573 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.03.2026. Verfasst von Darius G Buriman und 9 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School Medicine, "Victor Babeș" University of Medicine and Pharmacy of Timișoara, E. Murgu Sq., No. 2, 300041 Timișoara, Romania. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Sodium-Glucose Transporter 1, Sodium-Glucose Transporter 2, Blood Vessels. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Victor Babeș” University of Medicine and Pharmacy from Timisoara, Romania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sodium-glucose co-transporter (SGLT) inhibitors are a novel class of glucose-lowering drugs with beneficial pleiotropic effects that have been widely investigated in the past decade in several experimental models and patients in the absence of diabetes. There are two types of transporters: the SGLT1 isoform that is distributed across a broad range of tissues, including the cardiovascular system, and the SGLT2 isoform, which is mostly expressed in renal proximal tubular cells. It is known that inflammation and oxidative stress are key contributors to vascular damage and the progression of atherosclerosis. SGLT inhibitors have demonstrated multiple benefits that contribute to improved vascular health, including alleviation of endothelial function, anti-inflammatory and antioxidative effects, and mitigation of arterial stiffness, all contributing to blood pressure decrease. An increasing body of research has tackled the molecular and cellular mechanisms of their chronic and, more recently, acute cardiovascular beneficial effects. This narrative review specifically delves into the direct vasculoprotective effects of SGLT2 and dual SGLT1/2 inhibitors, summarizing their off-target mechanisms described in various experimental settings (animal models, animal and human cell lines/samples).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoglycemic AgentsSodium-Glucose Transporter 1Sodium-Glucose Transporter 2Blood VesselsSodium-Glucose Transporter 2 InhibitorsHumansAnimalsVascular StiffnessOxidative Stress

Stichwörter der Autor:innen

animal modelscell lineshuman samplesnon-diabetic settingsoff-target effectssodium-glucose cotransporter inhibitorsvascular protective mechanisms

Substanzen

Hypoglycemic AgentsSodium-Glucose Transporter 1Sodium-Glucose Transporter 2Sodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Doctoral School Medicine, "Victor Babeș" University of Medicine and Pharmacy of Timișoara, E. Murgu Sq., No. 2, 300041 Timișoara, Romania.
  • Department III Functional Sciences-Pathophysiology, "Victor Babeș" University of Medicine and Pharmacy of Timișoara, E. Murgu Sq. No. 2, 300041 Timișoara, Romania.
  • Center for Translational Research and Systems Medicine, "Victor Babeș" University of Medicine and Pharmacy of Timișoara, E. Murgu Sq. No. 2, 300041 Timișoara, Romania.
  • Department of Cardiology-Clinic of Cardiovascular Surgery, "Victor Babeș" University of Medicine and Pharmacy of Timișoara, 300041 Timișoara, Romania.
  • Research Center of the Institute for Cardiovascular Diseases of Timisoara, G. Adam Str. No. 13A, 300310 Timișoara, Romania.
  • School of Biology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.

ORCID-Profile: Darius G Buriman, Horea B Feier, Antigone Lazou, Attila Kiss, Bruno K Podesser, Maria D Dănilă

Förderung

  • “Victor Babeș” University of Medicine and Pharmacy from Timisoara, Romania

Zitieren

APA

Buriman, D. G., Noveanu, L., Furdui-Lința, A. V., Feier, H. B., Lazou, A., Kiss, A., Podesser, B. K., Dănilă, M. D., Sturza, A., & Muntean, D. M. (2026). Vasculoprotective Effects of Sodium-Glucose Co-Transporter Inhibitors in Non-Diabetic Experimental Settings: A Narrative Review. International Journal of Molecular Sciences, 27(6), 2573. https://doi.org/10.3390/ijms27062573

Vancouver

Buriman DG, Noveanu L, Furdui-Lința AV, Feier HB, Lazou A, Kiss A, et al. Vasculoprotective Effects of Sodium-Glucose Co-Transporter Inhibitors in Non-Diabetic Experimental Settings: A Narrative Review. International Journal of Molecular Sciences. 2026;27(6):2573. doi:10.3390/ijms27062573

BibTeX
@article{Buriman2026,
  author = {Buriman, Darius G and Noveanu, Lavinia and Furdui-Lința, Adina V and Feier, Horea B and Lazou, Antigone and Kiss, Attila and Podesser, Bruno K and Dănilă, Maria D and Sturza, Adrian and Muntean, Danina M},
  title = {Vasculoprotective Effects of Sodium-Glucose Co-Transporter Inhibitors in Non-Diabetic Experimental Settings: A Narrative Review},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {6},
  pages = {2573},
  doi = {10.3390/ijms27062573}
}
Kostenlos starten →